Titan Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 05/15/2025 | 11.96 K | $42.22 K | 100.00% | 1.31% |
| UBS GROUP AG | 05/13/2025 | 2.59 K | $9.16 K | -2.74% | 0.28% |
| CORECAP ADVISORS, LLC | 05/09/2025 | 88 | $311 | 100.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 18 | $64 | 5.88% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 15 | $49 | 0.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 05/14/2025 | 12 | $42 | 0.00% | 0.00% |
| BLACKROCK, INC. | 05/02/2025 | 6 | $21 | 100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2025 | 4 | $15 | 33.33% | 0.00% |
| GLOBAL WEALTH STRATEGIES & ASSOCIATES | 04/02/2025 | 2 | $7 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 1 | $4 | 0.00% | 0.00% |
| CALDWELL SUTTER CAPITAL, INC. | 04/16/2025 | 1 | $4 | 0.00% | 0.00% |
| ST GERMAIN D J CO INC | 04/09/2025 | 1 | $4 | 0.00% | 0.00% |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 04/25/2025 | 1 | $4 | 0.00% | 0.00% |
| 05/02/2025 | 1 | $4 | 0.00% | 0.00% | |
| CAPE INVESTMENT ADVISORY, INC. | 05/16/2025 | 1 | $4 | 0.00% | 0.00% |
| NEMES RUSH GROUP LLC | 05/07/2025 | 1 | $4 | 0.00% | 0.00% |
| 05/20/2025 | 1 | $4 | 100.00% | 0.00% | |
| MCF ADVISORS LLC | 05/06/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Titan Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 8 institutional investors and hedge funds held shares of Titan Pharmaceuticals, Inc.. The most heavily invested institutionals were:
CITADEL ADVISORS LLC: 11,961
UBS Group AG: 2,594
CoreCap Advisors, LLC: 88
BANK OF AMERICA CORP /DE/: 18
MORGAN STANLEY: 4
WELLS FARGO & COMPANY/MN: 1
1.61% of Titan Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 14.69 K shares in the last 24 months. This purchase volume represents approximately $71.25 K in transactions.